...
首页> 外文期刊>Diagnostic pathology >Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review
【24h】

Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review

机译:甲露甲状腺癌与萨拉达奇癌分化:案例报告和文献综述

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background Parathyroid carcinoma (PC) is a rare thyroid tumor. PC with sarcomatoid differentiation(PCSD) is even rarer and its exact etiology remains unclear. We here report a case of PCSD, and present the clinicopathological features and pathological diagnosis and review the literature. Case presentation A 71-year-old man presented with a mass of 4.5?cm?×?3.5?cm in the right neck. The tumor was composed of nest-like transparent cells, and the septum had heterotypic rhabdoid cells with sarcomatoid differentiation. Immunophenotype was as follows: myogenic differentiation 1(MyoD1), myogenin and desmin were positive; clear cells were positive for chromogranin A(CGA), synaptophysin(Syn) and GATA-3; and Ki-67 proliferation index was 40%. Hematoxylin and eosin staining and immunohistochemistry were performed. The patient was diagnosed with PCSD, and died 6?months after surgery. Conclusions PCSD is a rare type of primary parathyroid tumor with high malignancy and poor prognosis. Definitive diagnosis should be based on histopathological morphology and immunophenotype, and surgical treatment should be performed as soon as possible.
机译:摘要背景甲状旁腺癌(PC)是一种罕见的甲状腺肿瘤。具有SARCAMATOID分化(PCSD)的PC甚至罕见,其确切的病因仍然不清楚。我们在这里举报了PCSD的情况,并呈现临床病理特征和病理诊断并审查文献。案例介绍一个71岁的男子呈现出4.5?厘米的质量?×3.5?3.5?厘米。肿瘤由巢状透明细胞组成,隔膜具有具有SARCAMATOID分化的异型Rhabdoid细胞。免疫蛋白型如下:肌源性分化1(Myod1),肌原素和去霉素是阳性的;透明细胞对于Chormogranin A(CGA),突触蛋白(SYN)和GATA-3是阳性的; Ki-67增殖指数为40%。进行血清素和曙红染色和免疫组化。患者被诊断患有PCSD,并在手术后死亡6个月。结论PCSD是一种罕见的寄生甲状旁腺肿瘤,恶性肿瘤高,预后差。明确的诊断应基于组织病理学形态和免疫蛋白型,并且应尽快进行手术治疗。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号